Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) Return on Sales (2019 - 2021)

Alx Oncology Holdings' Return on Sales history spans 3 years, with the latest figure at 0.35% for Q1 2021.

  • On a quarterly basis, Return on Sales fell 27.0% to 0.35% in Q1 2021 year-over-year; TTM through Mar 2021 was 0.35%, a 30.0% decrease, with the full-year FY2020 number at 0.08%, down 4.0% from a year prior.
  • Return on Sales hit 0.35% in Q1 2021 for Alx Oncology Holdings, down from 0.08% in the prior quarter.
  • Over the last five years, Return on Sales for ALXO hit a ceiling of 0.02% in Q3 2019 and a floor of 0.35% in Q1 2021.
  • Historically, Return on Sales has averaged 0.12% across 3 years, with a median of 0.08% in 2020.
  • Biggest five-year swings in Return on Sales: decreased -2bps in 2020 and later decreased -27bps in 2021.
  • Tracing ALXO's Return on Sales over 3 years: stood at 0.06% in 2019, then fell by -28bps to 0.08% in 2020, then tumbled by -326bps to 0.35% in 2021.
  • Business Quant data shows Return on Sales for ALXO at 0.35% in Q1 2021, 0.08% in Q4 2020, and 0.15% in Q3 2020.